Multimedia

Oct. 05, 2016
References
  1. Habif TP. Premalignant and malignant nonmelanoma skin tumors. In: Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 6th ed. New York, N.Y.: Mosby Elsevier; 2016. http://www.clinicalkey.com. Accessed March 26, 2016.
  2. Niederhuber JE, et al., eds. Nonmelanoma skin cancers: Basal cell and squamous cell carninomas. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed March 26, 2016.
  3. AskMayoExpert. Basal cell carcinoma. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  4. What you need to know about melanoma and other skin cancers. National Cancer Institute. http://www.cancer.gov/cancertopics/wyntk/skin. Accessed May 16, 2016.
  5. NCCN clinical practice guidelines in oncology: Basal cell skin cancer. Version 1.2016. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed March 26, 2016.
  6. ToxFAQx for arsenic. Agency for Toxic Substances & Disease Registry. http://www.atsdr.cdc.gov/toxfaqs/tf.asp?id=19&tid=3. Accessed June 2, 2016.
  7. Drugs approved for skin cancer. National Cancer Institute. http://www.cancer.gov/about-cancer/treatment/drugs/skin. Accessed May 16, 2016.
  8. Basal cell carcinoma. American Academy of Dermatology. https://www.aad.org/public/diseases/skin-cancer/basal-cell-carcinoma. Accessed June 2, 2016.